{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:59:05Z","timestamp":1771567145899,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.129","type":"journal-article","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T22:03:55Z","timestamp":1312841035000},"page":"7727-7732","source":"Crossref","is-referenced-by-count":19,"title":["Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003\u20132010"],"prefix":"10.1016","volume":"29","author":[{"given":"Young June","family":"Choe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heeyeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Nam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geun-Ryang","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Koo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.07.129_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7525-3-18","article-title":"Values for preventing influenza-related morbidity and vaccine adverse events in children","volume":"3","author":"Prosser","year":"2005","journal-title":"Health Qual Life Outcomes"},{"issue":"October (6910)","key":"10.1016\/j.vaccine.2011.07.129_bib0010","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bmj.307.6910.988","article-title":"Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial","volume":"307","author":"Govaert","year":"1993","journal-title":"BMJ"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.07.129_bib0015","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jama.1990.03450090075029","article-title":"Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial","volume":"264","author":"Margolis","year":"1990","journal-title":"JAMA"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.07.129_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/oxfordjournals.aje.a112273","article-title":"Comparative trial of influenza vaccines. II. Adverse reactions in children and adults","volume":"104","author":"Barry","year":"1976","journal-title":"Am J Epidemiol"},{"issue":"October (16)","key":"10.1016\/j.vaccine.2011.07.129_bib0025","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jama.296.16.1990","article-title":"Safety of trivalent inactivated influenza vaccine in children 6\u201323 months old","volume":"296","author":"Hambidge","year":"2006","journal-title":"JAMA"},{"issue":"July (32)","key":"10.1016\/j.vaccine.2011.07.129_bib0030","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1016\/j.vaccine.2009.05.023","article-title":"Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6\u201323 months of age","volume":"27","author":"Rosenberg","year":"2009","journal-title":"Vaccine"},{"issue":"March (15)","key":"10.1016\/j.vaccine.2011.07.129_bib0035","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2011.07.129_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.129_bib0045","first-page":"178","article-title":"Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Advisory Committee on Causality Assessment","volume":"78","author":"Collet","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.07.129_bib0050","unstructured":"Immunization safety surveillance: guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization (WPRO\/EPI\/99.01). Geneva: World Health Organization; 1999."},{"issue":"January (3)","key":"10.1016\/j.vaccine.2011.07.129_bib0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"issue":"August (31)","key":"10.1016\/j.vaccine.2011.07.129_bib0060","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"August (31)","key":"10.1016\/j.vaccine.2011.07.129_bib0065","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1016\/j.vaccine.2007.04.059","article-title":"Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Halperin","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.129_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain-Barre syndrome","volume":"32","author":"Haber","year":"2009","journal-title":"Drug Saf"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2011.07.129_bib0075","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1008553","article-title":"Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China","volume":"364","author":"Liang","year":"2011","journal-title":"N Engl J Med"},{"issue":"November (20)","key":"10.1016\/j.vaccine.2011.07.129_bib0080","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barre syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.07.129_bib0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amepre.2010.05.022","article-title":"Evaluation of Guillain-Barre syndrome among recipients of influenza vaccine in 2000 and 2001","volume":"39","author":"Burwen","year":"2010","journal-title":"Am J Prev Med"},{"issue":"November (9497)","key":"10.1016\/j.vaccine.2011.07.129_bib0090","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.129_bib0095","first-page":"29","article-title":"Reflections on the 1976 swine flu vaccination program","volume":"12","author":"Sencer","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.07.129_bib0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14760584.7.1.75","article-title":"Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience","volume":"7","author":"Iskander","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.07.129_bib0105","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/STROKEAHA.108.524983","article-title":"Prevalence of stroke and transient ischemic attack in Korean elders: findings from the Korean Longitudinal Study on Health and Aging (KLoSHA)","volume":"40","author":"Han","year":"2009","journal-title":"Stroke"},{"issue":"April (14)","key":"10.1016\/j.vaccine.2011.07.129_bib0110","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa025028","article-title":"Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly","volume":"348","author":"Nichol","year":"2003","journal-title":"N Engl J Med"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.07.129_bib0115","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jocn.2008.05.002","article-title":"Post-vaccination encephalomyelitis: literature review and illustrative case","volume":"15","author":"Huynh","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.129_bib0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000112507","article-title":"Anaphylaxis from the influenza virus vaccine","volume":"146","author":"Coop","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.07.129_bib0125","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00103-004-0946-9","article-title":"Adverse events following immunisation in Germany from 1.1.2001 to 31.12.2003","volume":"47","author":"Keller-Stanislawski","year":"2004","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.07.129_bib0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(97)70056-8","article-title":"Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991\u20131994","volume":"131","author":"Braun","year":"1997","journal-title":"J Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T22:36:36Z","timestamp":1560465396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11011790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":26,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11011790"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.129","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}